Hepatocyte Growth Factor and Its Receptor Signalling Complex as Targets in Cancer Therapy

Publisher： Bentham Science Publishers

E-ISSN： 1875-5992|10|1|2-6

ISSN： 1871-5206

Source： Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol.10, Iss.1, 2010-01, pp. : 2-6

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Expression of hepatocyte growth factor in breast cancer and its effect on prognosis and sensitivity to chemotherapy

By  

Molecular Medicine Reports, Vol. 11, Iss. 2, 2015-01 ,pp. : 1037-1042

Spandidos Publications

Access to resources Recommend Favorite

Epidermal Growth Factor Receptor-Targeted Therapy for Pancreatic Cancer

By Papageorgio Chris   Perry Michael  

Cancer Investigation, Vol. 25, Iss. 7, 2007-10 ,pp. : 647-657

Informa Healthcare

Access to resources Recommend Favorite

Vascular Endothelial Growth Factor and Vascular Endothelial Growth Factor Receptor Inhibitors as Anti-Angiogenic Agents in Cancer Therapy

By  

Recent Patents on Anti-Cancer Drug Discovery, Vol. 2, Iss. 1, 2007-01 ,pp. : 59-71

Bentham Science Publishers

Access to resources Recommend Favorite

Berberine targets epidermal growth factor receptor signaling to suppress prostate cancer proliferation in vitro

By  

Molecular Medicine Reports, Vol. 11, Iss. 3, 2015-01 ,pp. : 2125-2128

Spandidos Publications

Access to resources Recommend Favorite

Hepatocyte Growth Factor Activation Inhibitors – Therapeutic Potential in Cancer

By  

Anti-Cancer Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Anti-Cancer Agents), Vol. 10, Iss. 1, 2010-01 ,pp. : 47-57

Bentham Science Publishers

Access to resources Recommend Favorite